Elizabeth H.Z. Thompson

EVP, Head of Research & Dev · 2 filings · Latest: Mar 24, 2026

ACADIA PHARMACEUTICALS INC

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
ACAD	Elizabeth H.Z. Thompson	EVP, Head of Research & Dev	Mar 25, 2026	Sale	$21.47	3,435	$73.7K	3,280	Mar 27 12:00 AM
ACAD	Elizabeth H.Z. Thompson	EVP, Head of Research & Dev	Mar 24, 2026	Option Exercise	—	6,715	—	6,715	Mar 27 12:00 AM